UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Altered EBV specific immune control in multiple sclerosis

Journal of neuroimmunology, 2024-05, Vol.390, p.578343, Article 578343

Münz, Christian

2024

Volltextzugriff (PDF)

Immune checkpoints in T cells during oncogenic γ‐herpesvirus infections

Journal of medical virology, 2023-01, Vol.95 (1), p.e27840-n/a

Münz, Christian

2023

Volltextzugriff (PDF)

The Autophagic Machinery in Viral Exocytosis

Frontiers in microbiology, 2017-02, Vol.8, p.269-269

Münz, Christian

2017

Volltextzugriff (PDF)

Vaccination against the Epstein–Barr virus

Cellular and molecular life sciences : CMLS, 2020-11, Vol.77 (21), p.4315-4324

2020

Volltextzugriff (PDF)

EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010200-e1010200

2022

Volltextzugriff (PDF)

Latency and lytic replication in Epstein–Barr virus-associated oncogenesis

Nature reviews. Microbiology, 2019-11, Vol.17 (11), p.691-700

Münz, Christian

2019

Volltextzugriff (PDF)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo

mBio, 2019-01, Vol.10 (1)

2019

Volltextzugriff (PDF)

Role of human natural killer cells during Epstein-Barr virus infection

Critical reviews in immunology, 2014, Vol.34 (6), p.501-507

Muenz, Christian

2014

Volltextzugriff (PDF)

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

The Journal of immunology (1950), 2013-11, Vol.191 (10), p.4989-4995

2013

Volltextzugriff (PDF)

Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

Frontiers in immunology, 2017-09, Vol.8, p.1183-1183

Münz, Christian

2017

Volltextzugriff (PDF)

Immunodeficiencies that predispose to pathologies by human oncogenic y-herpesviruses

FEMS microbiology reviews, 2019-03, Vol.43 (2), p.181

2019

Volltextzugriff (PDF)

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Frontiers in immunology, 2018-02, Vol.9, p.238-238

Münz, Christian

2018

Volltextzugriff (PDF)

Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression

Cell host & microbe, 2017-07, Vol.22 (1), p.61-73.e7

2017

Volltextzugriff (PDF)

Patients with Epstein Barr virus‐positive lymphomas have decreased CD4+ T‐cell responses to the viral nuclear antigen 1

International journal of cancer, 2008-12, Vol.123 (12), p.2824-2831

2008

Volltextzugriff (PDF)

The autophagy machinery interacts with EBV capsids during viral envelope release

Proceedings of the National Academy of Sciences - PNAS, 2023-08, Vol.120 (34), p.e2211281120-e2211281120

2023

Volltextzugriff (PDF)

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

Annals of neurology, 2010-02, Vol.67 (2), p.159-169

2010

Volltextzugriff (PDF)

Editorial: EBV-induced T cell immunity in cancers

Frontiers in immunology, 2024-07, Vol.15, p.1454792

2024

Volltextzugriff (PDF)

MHC class II‐deficient mice allow functional human CD4+ T‐cell development

European journal of immunology, 2023-07, Vol.53 (7), p.e2250313-n/a

2023

Volltextzugriff (PDF)

Infectious diseases in humanized mice

European journal of immunology, 2013-09, Vol.43 (9), p.2246-2254

2013

Volltextzugriff (PDF)

Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas

Cell reports (Cambridge), 2013-10, Vol.5 (2), p.458-470

2013

Volltextzugriff (PDF)

Innate immune responses against Epstein Barr virus infection

Journal of leukocyte biology, 2013-12, Vol.94 (6), p.1185-1190

2013

Volltextzugriff (PDF)

Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection

Cell reports (Cambridge), 2013-12, Vol.5 (6), p.1489-1498

2013

Volltextzugriff (PDF)

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and gamma delta T cells

The Journal of experimental medicine, 2017-06, Vol.214 (6), p.1827-1841

2017

Volltextzugriff (PDF)

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection

Cell reports (Cambridge), 2021-05, Vol.35 (5), p.109056-109056, Article 109056

2021

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

ThemaInfections

ThemaEpstein-Barr Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(53)
Buchkapitel
(2)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(40)
Humans
(37)
Immunology
(21)
Animals
(20)
Herpesvirus 4, Human - Immunology
(18)
Epstein-Barr Virus Infections - Immunology
(15)
Mice
(14)
Lymphoma
(10)
Tumors
(10)
Cell Biology
(9)
T Cells
(9)
B-Lymphocytes - Virology
(8)
Herpesvirus 4, Human - Genetics
(8)
T-Lymphocytes - Immunology
(8)
Adult
(7)
B-Lymphocytes - Immunology
(7)
Epstein-Barr Virus Infections - Complications
(7)
Epstein-Barr Virus Nuclear Antigens - Immunology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Altered EBV specific immune control in multiple sclerosis

Immune checkpoints in T cells during oncogenic γ‐herpesvirus infections

The Autophagic Machinery in Viral Exocytosis

Vaccination against the Epstein–Barr virus

EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22

Latency and lytic replication in Epstein–Barr virus-associated oncogenesis

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo

Role of human natural killer cells during Epstein-Barr virus infection

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

Autophagy Proteins in Phagocyte Endocytosis and Exocytosis

Immunodeficiencies that predispose to pathologies by human oncogenic y-herpesviruses

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression

Patients with Epstein Barr virus‐positive lymphomas have decreased CD4+ T‐cell responses to the viral nuclear antigen 1

The autophagy machinery interacts with EBV capsids during viral envelope release

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

Editorial: EBV-induced T cell immunity in cancers

MHC class II‐deficient mice allow functional human CD4+ T‐cell development

Infectious diseases in humanized mice

PD-1 Blockade Aggravates Epstein-Barr Virus + Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4 + T Cell Dysregulations

Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas

Innate immune responses against Epstein Barr virus infection

Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and gamma delta T cells

KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection

Aktive Filter

Suchergebnisse filtern